FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 179 of 179

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
SLDB Nasdaq Solid Biosciences Inc. 2834
SLNO Nasdaq Soleno Therapeutics, Inc. 2834
SNDX Nasdaq Syndax Pharmaceuticals, Inc. 2834
SNY Nasdaq Sanofi 2834
SRZN Nasdaq Surrozen, Inc. 2834
SVRA Nasdaq Savara Inc. 2834
SXTP Nasdaq 60 Degrees Pharmaceuticals, Inc. 2834
TARS Nasdaq Tarsus Pharmaceuticals, Inc. 2834
TCRT Nasdaq Alaunos Therapeutics, Inc. 2834
TELO Nasdaq Telomir Pharmaceuticals, Inc. 2834
THRD Nasdaq Third Harmonic Bio, Inc. 2834
TNGX Nasdaq Tango Therapeutics, Inc. 2834
TOVX NYSE American Theriva Biologics, Inc. 2834
TRDA Nasdaq Entrada Therapeutics, Inc. 2834
TRUMY Over the counter Terumo Corporation 2834
TRVI Nasdaq Trevi Therapeutics, Inc. 2834
TTNP Nasdaq Titan Pharmaceuticals, Inc. 2834
UCBJY Over the counter UCB SA 2834
UPB Nasdaq Upstream Bio, Inc. 2834
VIR Nasdaq Vir Biotechnology, Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2834
VRNA Nasdaq Verona Pharma plc 2834
VYGR Nasdaq Voyager Therapeutics, Inc. 2834
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2834
WVE Nasdaq Wave Life Sciences Ltd. 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
XRTX Nasdaq XORTX Therapeutics Inc. 2834
ZURA Nasdaq Zura Bio Limited 2834
ZYME Nasdaq Zymeworks Inc. 2834
Results 150 through 179 of 179